Tag: pharmaceuticals

  • Insomnia Costs U.S. Employers Billions in Lost Productivity

    Researchers from universities, hospitals, and companies in the U.S. and Europe calculated the lost productivity of Americans suffering from insomnia at an annual cost of $63.2 billion to employers. Their findings from the study, funded by the pharmaceutical company Merck, appear in the 1 September issue of the journal Sleep (paid subscription required). The team…

  • Computer Model Tests Effects of Heart Rhythm Drugs

    Researchers at University of California in Davis have led the development of a computer model to test the effects of medications for arrhythmia — abnormal heart rhythm — before they are given to patients. The work of the team led by biophysicist Colleen Clancy is described in the 31 August issue of the journal Science…

  • Trial Finds New Drug Better Than Common Blood Thinner

    A clinical trial found that apixaban, an anticoagulant drug made by Bristol-Myers Squibb and Pfizer, does better in preventing stroke and blood clots in patients with atrial fibrillation, compared to the common drug warfarin.  The results were presented today at the European Society of Cardiology in Paris, and published online in the New England Journal…

  • FDA Approves Opioid Analgesic for Chronic Pain

    Janssen Pharmaceuticals in Raritan, New Jersey says the Food and Drug Administration has approved its drug Nucynta ER for the management of moderate to severe chronic pain in adults. The company is a division of drug manufacturer Johnson & Johnson. Nucynta ER is an oral analgesic taken twice daily, and prescribed when a continuous, around-the-clock…

  • Chili Pepper Ingredient Can Help Ease Sinus Problems

    A study led by a University of Cincinnati allergy researcher has found that a nasal spray containing an ingredient derived from hot chili peppers (Capsicum annum) may help relieve certain types of sinus inflammation. The findings by Jonathan Bernstein of the UC medical school and colleagues appear in the August issue of the journal Annals…

  • Institute of Medicine: Few Health Problems from Vaccines

    A committee of experts convened by the Institute of Medicine (IOM), one of the National Academies,  analyzed more than 1,000 research articles and concluded that few health problems are caused by or clearly associated with vaccines. The committee was chaired by Ellen Wright Clayton, who holds professorships in both pediatrics and law at Vanderbilt University…

  • Cambridge U.K. Spin-Off Gains $9.5 Million in Early Funding

    Mission Therapeutics, a research spin-off company from Cambridge University in the U.K., has raised £6 million ($US 9.5 million) in Series A funding from a European venture capital syndicate. Series A investments represent the first round of significant funds raised after an enterprise’s initial launch. The company specializes in the discovery and development of drugs…

  • People Without Jobs and Insurance Skip Medicine, Health Care

    A report from the Commonwealth Fund in New York says the vast majority of people who lost both their jobs and health insurance in the past two years skipped needed health care or did not fill prescriptions because of the cost. The data for the study come from the Commonwealth Fund’s 2010 Biennial Health Insurance…

  • New Treatment Fixes Tooth Decay Without Drilling

    Researchers at University of Leeds in the U.K. have developed a way of treating dental decay that reverses the damage caused by acid and re-builds teeth, without drilling. The technology developed at Leeds has been licensed to a company in Switzerland for commercialization. Dental cavities are caused by a process that begins with bacteria, which…

  • Computer Model Helps Pinpoint Cancer Cell Targets

    Medical and computer scientists in Israel and the U.K. have developed a computer model of cancer cell metabolism, which can help predict which drugs are lethal to cancer cells. Their work was part of a research study reported online last week in the journal Nature (paid subscription required). Many cancer drugs are now designed to…